leadf
logo-loader
LSE:DDDD

4D pharma plc

Receive alerts
Market:
LSE
Market Cap:
£203.66 m
Price
155.00 GBX
Change
4.73%
52 weeks high
174.64
52 weeks low
23.50

In brief

4D are pioneers in harnessing bacteria as a revolutionary new class of medicines – called live biotherapeutics.

Snapshot

Working in the emerging area of the human microbiome, the company has developed candidates in cancer, gastrointestinal and respiratory ailments, and autoimmune disease